Corticosteroid Injection Versus Nerve Block

Launched by UNIVERSITY OF MINNESOTA · Dec 10, 2024

Keywords

ClinConnect Summary

This clinical trial is looking at two ways to help relieve pain for people suffering from shoulder conditions like glenohumeral arthritis and rotator cuff arthropathy. The study will compare a common treatment called corticosteroid injection, which helps reduce inflammation and pain, with a method called suprascapular nerve block, which targets specific nerves in the shoulder to block pain signals. The goal is to find out which of these treatments works better for managing pain.

To participate in this trial, you need to be between 65 and 74 years old and have a diagnosis of either glenohumeral osteoarthritis, rheumatoid arthritis, or rotator cuff arthropathy. However, there are some people who won't be eligible, such as those with uncontrolled diabetes, allergies to steroids or anesthetics, pregnant women, and children under 18. If you join the study, you can expect to receive one of the two treatments and have your pain levels monitored over time. This research aims to explore new options for shoulder pain relief and help improve treatment for people facing these conditions.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • diagnosis of glenohumeral osteoarthritis, rheumatoid arthritis, or rotator cuff arthropathy who are being offered injection
• Exclusion Criteria:
• • uncontrolled diabetes (patients will be excluded if no HbA1c within a year or if it is 8 or greater"
• • known allergy to steroid or anesthetic
• • pregnant women
• • prisoners
• • patients with diminished capacity to consent to participation
• • children under 18 years of age
• • non-English speakers